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Abstract 
Introduction: Priapism is an uncommon disorder of involuntary prolonged erection beyond sexual excitement or 
desire. Herein, we present a rare case of priapism resulting from traditional circumcision under regional anesthesia 
with dorsal penile nerve block by xylocaine, which was successfully treated by intracavernosal injection of metarami-
nol bitartrate.
Case description: A 37-year-old man visited our out-patient department for a penile erection, which had been 
observed during the surgery, lasting for 21 days. 10 days after circumcision, he accepted simple corporeal aspiration in 
another hospital but it had no effect. In our hospital, he was injected intracavernosally twice a day, with 2 mg meta-
raminol bitartrate diluted in 1 ml normal saline every time. Complete resolution of penile tumescence was achieved 
after injection for 7 days, no complications were observed.
Discussion and evaluation: Priapism developed following circumcision is very uncommon. This particular case was 
diagnosed as high-flow non-ischemic priapism, and is the first reported event of priapism resulting from circumcision 
which was finally successfully treated with the efficient and minimally invasive method of intracavernosal injection of 
metaraminol bitartrate.
Conclusions: Intracavernous injection of metaramino bitartrate might be a simple, effective and safe method for 
relief of priapism associated with circumcision. Yet, more clinical studies are needed to validate the effectiveness of 
intracavernosal metaramino bitartrate for post-circumcision priapism.
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Introduction
Priapism is an uncommon disorder of involuntary pro-
longed erection beyond sexual excitement or desire, 
usually accompanied by penile pain. Early and effec-
tive treatment could avoid long-term erectile dysfunc-
tion (ED). The most common causes were trauma (Koga 
et al. 1990), intracavernosal pharmacotherapy for ED, the 
hyperviscosity syndromes, psychotropic medications, 
malignant infiltration (Keoghane et  al. 2002), spinal or 
general anaesthesia (Van Arsdalen et al. 1983; Roy 1984) 
and so on. Nevertheless, the mechanisms have not been 
fully understood.
Herein, we report a rare case of priapism result from 
traditional circumcision that was successfully treated by 
intracavernosal injection of metaraminol bitartrate.
Case description
An otherwise healthy 37-year-old man was admitted 
on April 2, 2015 complaining of an erection, lasting for 
21 days. He had accepted traditional circumcision under 
regional anesthesia with dorsal penile nerve block by 
xylocaine 21 days ago. Penile erection was noticed during 
the operation, but was not paid enough attention to. Nev-
ertheless, Priapism was persistent and did not respond to 
simple corporeal aspiration 10 days after development of 
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the priapism, but without discomfort of dysuria or pain. 
He then came to our out-patient department. On physi-
cal examination the corpora cavernosa were erect and 
the corpus spongiosum was flaccid. He had received 
ultrasonography in another hospital where he accepted 
corporeal aspiration, but uncarefully missed the report. 
Rapidly, we got the cavernosal blood gas analysis, and 
the result showed pH, 7.437; carbon dioxide pressure, 
42.5  mmHg; oxygen pressure, 88.5  mmHg; and oxygen 
saturation, 97.5  %. Further MRI showed both sides of 
corpus cavernosum increased significant thickly, as well 
as the corpus spongiosum (Fig. 1). Based on the history, 
clinical manifestation and examination results, we then 
made the diagnosis of high flow non-ischaemic priapism 
in this case.
He was then injected intracavernosally at one side of 
the penile draft twice a day over 7 days, with 2 mg meta-
raminol bitartrate diluted in 1  ml normal saline every 
time. A total of 28 mg was given. Some softening of the 
penis was noticed at the first injection although it became 
hard again 30 min later. The second injection resulted in 
moderate detumescence. The penis achieved complete 
flaccid after the fourteenth injection and remained soft. 
Blood pressure and heart rate which were measured 
immediately before and 3  min after metaraminol injec-
tion, and there were no significant changes (not shown). 
Follow-up for 2 months showed that no recurrent penile 
tumescence was observed.
Discussion and evaluation
Priapism is a rare condition defined as a persistent penile 
erection arising from dysfunction of the mechanisms 
regulating penile tumescence and flaccidity, and the etiol-
ogy is still unclear.
Priapism developed following circumcision is even 
more uncommon. As far as we know, there have been 
only two reports about priapism associated with circum-
cision till now. Canter and Coskuner (2011) presented a 
case that priapism developed 2  days after circumcision 
but did not respond to decompression attempts with 
pharmacologic treatment, and glandulocavernous shunt 
was needed in the first 12  h after development of the 
priapism. But severe penile necrosis developed almost 
3  weeks after circumcision and priapism. Another case 
of long-term priapism that caused by circumcision, com-
plicated local skin necrosis, was treated with traditional 
Chinese therapy, such as bone scraping and depletion 
therapy, and achieved satisfactory effect (Jin et al. 2005). 
Both of the above two cases were not without drawbacks, 
result in either ischemia event or further-term ED. To 
the best of our knowledge, this particular case is the first 
reported event of priapism resulting from circumcision 
which was finally successfully treated with an efficient 
and minimally invasive method, intracavernosal injection 
of metaraminol bitartrate.
It is widely accepted that there are two different types 
of priapism. One is low-flow ischemic priapism which 
Fig. 1 Magnetic resonance imaging of the erected penis. MRI (Heavily T2-weighted image) shows both sides of corpus cavernosum (arrow) 
increased significant thickly, as well as the corpus spongiosum (arrowhead). a Coronal view, b sagittal view
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is caused by stagnation of blood in the corpus caver-
nosum, the other is high-flow non-ischemic which is 
caused by an excess of arterial inflow relative to venous 
outflow (Koga et  al. 1990). There might be a limitation 
in this case that we did not reexamine ultrasonography 
when the patient arrived at our department. But the role 
of cavernosal blood gas analysis in typing diagnosis of 
priapism has been generally confirmed by clinical prac-
tice. The blood gas result was normal in this case. Moreo-
ver, except for the noneffective corporeal aspiration, the 
patient did not accept any other treatment before coming 
to our department. Thus the erected penis had formed 
mild corporal fibrosis when he arrived, according to the 
MRI result. Taken together, our case was considered to 
be high-flow non-ischemic priapism. As the therapy of 
high-flow priapism is not as urgent as that of low-flow 
priapism because there is no risk of ischemia, conserva-
tive therapeutic and close observation is recommended 
by most urologists (Pautler and Brock 2001). Thus we 
chose intracavernosal treatment considering the minimal 
trauma.
Brindley (1984) was the first one to report that intra-
cavernosal injection of metaraminol causes shrinkage 
of the penis. He described that the alpha-adrenergic 
receptor existed in the cavernous smooth muscle and 
penile arteries. Intracorporeal instillation of metarami-
nol, which is an alpha-adrenergic agent, contracts penile 
arteries and the arterial flow in the corpus cavernosum 
decrease, and thus effective to priapism. This method was 
then widely practiced in impotent patients who develop 
priapism as a complication of pharmacologically induced 
penile erection (Brindley 1986). Then, Tsai and Hong 
found that intracavernosal injection of 10–25 pg metara-
minol is a simple, effective and safe method for immedi-
ate relief of intraoperative penile erection. It can be used 
in patients with either regional block or general anaes-
thesia (Tsai and Hong 1990). Koga et  al. (1990) firstly 
reported that a 30-year-old male with post-traumatic 
priapism for 7  days was treated successfully by metara-
minol bitartrate injection into the corpus cavernosum. In 
that case, metaramino bitartrate 2–4 mg (20 % solution) 
was injected into the corpus cavernosum six times over 
10 days, and a total dose of 19 mg was given. Treatment 
of priapism using metaraminol had been suggested in the 
hospital setting as described above. Interestingly, Mcdon-
ald firstly reported successful management of recurrent 
priapism secondary to sickle cell trait using self-adminis-
tered injections of intracavernosal metaraminol at home, 
with the frequency as often as once daily using 5–10 mg 
of drug (McDonald and Santucci 2004).
Through analysis of the literature data and patient’s 
general situation, we chose 2  mg metaramino bitartrate 
as the initial dose. The blood pressure and heart rate were 
monitored immediately before and 3 min after injection, 
and no changes were observed. Since starting injection, 
he did not report any systemic side effects associated 
with sympathomimetics such as headache, shortness of 
breath, flushing or chest pain. Some decrease of rigidity 
was observed 5 min after injection, but the penis became 
elastic-hard again 30 min later. We then injected as often 
as twice a day, 2  mg metaramino bitartrate each time. 
Complete resolution of penile tumescence was achieved 
after injection for 7 days. After 2 months of follow-up, no 
recurrent priapism is found, and the erectile function is 
general normal.
Conclusions
We concluded that intracavernous injection of meta-
ramino bitartrate might be a simple, effective and safe 
method for relief of priapism associated with circumci-
sion. It should be tried at first before any more invasive 
methods, such as corporeal aspiration or shunting tech-
niques. The first few times of injections may not be so 
effective, but our case shows that repeat injection sev-
eral times may be still effective. Yet, more clinical stud-
ies are needed to gather experience about the category of 
priapism and corresponding prescriptions of metaramino 
bitartrate.
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